Rapid visual detection of Mycoplasma gallisepticum by combining recombinase-aided amplification with lateral-flow dipstick assay Authors: Huiyong Xuan, Shu Wang, XinYi Ren, Fang Wang, Gang Lu, Hongwei Gao, Yaocheng Cui Published: 2026 ABSTRACT AbstractMycoplasma gallisepticum (MG) is a significant avian pathogen that adversely affects chickens and turkeys globally and is classified as a notifiable disease agent by the World Organisation for Animal Health. Therefore, rapid and accurate diagnosis is a critical factor in controlling MG infections. This study established a simple, rapid, and visual detection method for MG using recombinase-aided amplification (RAA) combined with a lateral flow dipstick (LFD). Following primer and probe screening, the RAA-LFD method was optimized for primer concentration, probe concentration, reaction temperature, and time, and its specificity and sensitivity were analyzed. The results demonstrated that under isothermal conditions at 39°C, RAA could amplify the target gene within 20 minutes, and the products could be visualized via LFD within 5 minutes. The method showed no cross-reactivity with Mycoplasma synoviae, Mycoplasma bovis, Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, Enterococcus faecium, or Enterococcus faecalis. Furthermore, the RAA-LFD method exhibited high sensitivity and good reproducibility, with a detection limit of 10 copies/μL. A total of 100 clinical samples suspected of MG infection were tested using RAA, PCR, and real-time fluorescence quantitative PCR (qPCR). The concordance rates between the RAA detection method and conventional PCR or qPCR were 96% and 98%, respectively. These results indicate that the established RAA-LFD method is easy to operate, highly specific, and sensitive, making it suitable for grassroots-level field diagnosis of MG infections.Keywords: Avian mycoplasmosis, Isothermal amplification, Point-of-care testing, Diagnostic methods Introduction Mycoplasma gallisepticum is a pathogenic avian mycoplasma that poses a threat to chickens worldwide and is classified as a notifiable disease by the World Organization for Animal Health (Yehia et al., 2023). It causes chronic respiratory disease and reproductive system damage, characterized by nasal discharge, tracheal rales, coughing, dyspnea, and salpingitis. Consequently, it leads to reduced weight gain, decreased egg production, lowered hatchability, poor carcass quality, and increased susceptibility to other diseases in the chickens (Ishfaq et al., 2020; Mugunthan et al., 2023). Economically, MG is estimated to cause annual losses of approximately 140 million US dollars solely in the layer production sector of the United States (Chaidez-Ibarra et al., 2022). In addition, existing studies have shown that MG is prevalent in Chinese indigenous chickens, inflicting substantial economic losses on China's poultry industry (Wei et al., 2023; Fang et al., 2025). Therefore, developing early, rapid, and simple detection methods is of great significance for controlling the spread of MG. Traditional and novel diagnostic methods have been established and applied to diagnosing MG. These include bacterial culture, serological tests (such as ELISA), and molecular techniques (such as conventional PCR and quantitative real-time PCR) (Sprygin et al., 2010; Ball et al., 2020; Elyazeed et al., 2020; Matucci et al., 2023). Although these methods are reliable, their dependence on sophisticated instruments and skilled personnel limits their applications in on-site testing. To solve these limitations, isothermal nucleic acid amplification technologies have emerged, including Recombinase-aided amplification, Rolling Circle Amplification, Loop-Mediated Isothermal Amplification (LAMP), and Strand Displacement Amplification (Lee et al., 2022; Nguyen et al., 2022; Ghosh et al., 2025). However, Rolling Circle Amplification, Loop-Mediated Isothermal Amplification (LAMP), and Strand Displacement Amplification suffer from complex primer design and the need for a relatively large number of primers, which also limits their wide application. As a representative isothermal technology for nucleic acid detection, RAA stands out due to its simpler primers, easier operation, no requirement for specialized equipment, and lower amplification temperature. Lateral flow dipstick technology is a portable auxiliary tool that has been successfully applied in nucleic acid-based, antigen-based, and antibody-based diagnostics, with results directly observable by the naked eye (Ginés et al., 2021). Therefore, LFD holds potential for on-site detection. RAA-LFD enables the visual detection of amplified products via the dipstick, making RAA technology more suitable for Point-of-Care (POC) testing applications. This detection method utilizes recombinase to facilitate the binding of primers to the complementary sequences of double-stranded DNA (dsDNA) and relies on single-stranded DNA binding protein (SSB protein) to prevent primer dissociation (Homklinkaew et al., 2023). DNA polymerase carries out replication through its strand displacement activity, thereby synthesizing new complementary DNA strands (Tian et al., 2023). After short-term incubation at 37 to 42°C, the amplified products can be detected via the dipstick, typically taking approximately one hour, which makes RAA particularly suitable for on-site detection (Yu et al., 2025). Currently, RAA-LFD has been applied to the detection of various pathogens in humans and animals (Jiang et al., 2025). In this study, a rapid RAA-LFD detection method was established, which exhibits strong specificity and high sensitivity for the visual detection of MG. This technology enables real-time monitoring of MG, providing a timely basis for MG risk assessment and control strategies. Materials and methods Bacterial strains and clinical samples Four strains of MG, along with strains of Mycoplasma synoviae, Mycoplasma bovis, Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis (all clinically isolated and preserved in the laboratory), were used. A total of 100 throat samples were collected from chickens suspected of MG infection. The samples were collected with sterile cotton swabs, placed in PBS buffer, and then immediately transported back to the laboratory. All materials were stored at −80°C. Extraction of nucleic acid The DNA templates of MG, Mycoplasma synoviae, Mycoplasma bovis, Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis were all extracted in accordance with the instructions of the DNA extraction kit (Novizan Biotechnology Co., Ltd., Nanjing, China). The concentration of the extracted DNA was determined using a microvolume nucleic acid and protein analyzer (NanoDrop 2000). All DNA samples were stored at −20°C. Design and screening of primers Based on the conserved sequence of the mgc2 and pvpA gene of MG (GenBank accession number: U34842.1 and AF035624.1) and in accordance with the requirements in the instruction manual of the RAA (Basic) kit (Nanjing Wobo Biotechnology Co., Ltd., Nanjing, China), four pairs of primers were designed (Table 1). The RAA reaction system (50 μL) was prepared according to the following components: buffer A 25 μL; forward primers (10 μM) and reverse primers (10 μM) 2 μL each; DNA template 5 μL; 13.5 μL sterile water; buffer B 2.5 μL. The DNA extracted from MG strain SHZ-1 was used as the amplification template. The negative control group replaced the DNA template with 5 μL sterile water. The reaction system was incubated in a water bath at 39°C for 20 minutes. The RAA amplification product was purified by phenol-chloroform, and then detected by 2% agarose gel electrophoresis. The finally selected optimal primer pair was used for subsequent RAA-LFD condition optimization. Table 1Oligonucleotide primers and probes designed in this study for the detection of Mycoplasma gallisepticum targeting the mgc2 and pvpA genes.Table 1 dummy alt textPrimersGenesSequences (5′→3′)Product size (bp)MG-F1mgc2TGCCACCTAACCAAATGGGAATGCGACCAG166MG-R1GCTTTATTTCCCATCGGCACCCCACCACCAMG-F2CTAATCCCCAACAAAGAATTAACCCACAGG280MG-R2CCTACAGCTTTATTTCCCATCGGCACCCCAMG-F3GTCCTAATCCCCAACAAAGAATTAACCCACAG218MG-R3ATTCATATTAGGCATTTGGTTAGGGAAGTTTGMG-F4pvpAGCTCTTATTCTATTGTCAGGGATTGCACTAAC226MG-R4CAAGTAATACAATCCCTACTACAAGTCCAGCAMG-R1bmgc2Biotin-GCTTTATTTCCCATCGGCACCCCACCACCAProbe 1FAM-AACCAAATGCCCCCACAAATGGGAGGAATGCC[THF]CCAAGACCAAACTTCC—C3 SpacerProbe 2FAM-AGACCAAACTTCCCTAACCAAATGCCTAATAT[THF]AATCAACCAAGACCA-C3 Spacer Oligonucleotide primers and probes designed in this study for the detection of Mycoplasma gallisepticum targeting the mgc2 and pvpA genes. Design and screening of probes The optimal primer pair screened above was MG F1/MG R1. After performing the RAA reaction with this primer pair, a clear and bright band of the expected size could be observed in the agarose gel. Subsequently, the 5′ end of the reverse primer was labeled with biotin and named MG R1b. According to the instructions of the RAA (LFD) Kit (Nanjing Vazyme Biotech Co., Ltd., Nanjing, China), two probes were designed (Table 1). The 5′ end of each probe was labeled with a FAM fluorophore, a tetrahydrofuran (THF) site was placed in the middle of the probe, and the 3′ end was blocked by a C3 phosphorylation spacer. Each probe was validated by the RAA-LFD assay without adding MG DNA template, to detect potential false-positive signals on the dipstick caused by the primer-probe complex. Establishment of RAA-LFD assay A 50 μL RAA reaction system was established according to the instructions of the RAA Nucleic Acid Amplification Test Strip Kit (Nanjing Vazyme Biotech Co., Ltd., Nanjing, China). The premix consisted of 25 μL of A Buffer, 12.9 μL of ddH₂O, 2 μL of forward primer (2 μM), 2 μL of reverse primer (2 μM), 0.6 μL of probe (2 μM). The premix was thoroughly mixed in a clean PCR tube and then added to the detection unit tube containing the lyophilized enzyme preparation. Subsequently, 5 μL of the DNA sample to be tested was added to the detection unit tube, and 2.5 μL of B Buffer was dropped onto the inner side of the tube cap. The tube cap was tightly closed, the tube was gently inverted and flicked 5-6 times to ensure thorough mixing, centrifuged at 12000 rpm for 10 seconds, and then incubated in a 39°C constant-temperature water bath for 20 minutes. After the reaction, the 50 μL reaction mixture was diluted with sterile water or PBS at a ratio of 50 μL reaction mixture to 300 μL diluent, and detected using a universal nucleic acid detection test strip (Nanjing Vazyme Biotech Co., Ltd., Nanjing, China). The experimental procedure is shown in Fig. 1. Schematic diagram of the RAA-LFD detection platform. DNA is extracted from clinical samples, and the target gene is rapidly amplified using RAA technology. The amplification products are incubated in a constant temperature water bath at 39°C for 20 minutes. After the reaction, the 50 μL reaction mixture is diluted with sterile water or PBS (50 μL reaction mixture: 300 μL diluent), and detection is performed using a universal nucleic acid test strip. Optimization of RAA-LFD reaction conditions The selected optimal primer pair was diluted. While keeping other components of the reaction system unchanged, forward and reverse primers were added to the system at final concentrations of 0.5, 1, 1.5, 2, 3, and 4 μM, respectively, to screen for the optimal primer concentration. Based on the optimal primer concentration, the probe concentration was diluted to 0.5, 1, 1.5, 2, 3, and 4 μM to screen for the optimal probe concentration. With the optimal primer and probe concentrations confirmed, the reaction temperature was set to 25, 30, 35, 37, 39, and 41°C separately, and each reaction was incubated for 30 minutes to screen for the optimal reaction temperature. Finally, the reaction time was set to 10, 15, 20, 25, and 30 min to optimize the optimal reaction time. Specificity test Using the DNA of MG, Mycoplasma synoviae, Mycoplasma bovis, Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis as templates, with ddH₂O as the negative control template, RAA-LFD assay was performed under the optimized optimal reaction conditions to detect the specificity of this method. Construction of standard plasmid Polymerase chain reaction amplification of the mgc2 gene from MG was performed. The full-length PCR amplification primers for the MG mgc2 gene were as follows: forward primer: TTGGAGTTAGCTTTGTGTTCTCG; reverse primer: ATTTTGCGGTGGAAAACCAGCTC. The PCR amplification reaction system was composed of 10 μL of PCR Mix, 6 μL of ddH₂O, 1 μL each of forward and reverse primers (10 μM), and 2 μL of template DNA. The reaction program was set as follows: pre-denaturation at 95°C for 5 minutes; 32 cycles of denaturation at 95°C for 30 seconds, annealing at 61°C for 30 seconds, and extension at 72°C for 30 seconds; final extension at 72°C for 7 minutes. After the reaction, the amplified fragment was ligated into the pMD19-T vector and transformed into DH5α competent cells. Positive strains were screened and verified by colony PCR, then sent to Shanghai Sangon Biotech Co., Ltd. for sequencing, and the sequencing results were aligned in NCBI. Plasmid DNA was extracted according to the instructions of the plasmid extraction kit and stored at −20°C. After verifying the correctness of the recombinant plasmid (pMD19-mgc2) by PCR and sequencing, its concentration was determined using an ultramicro spectrophotometer, and the copy number was calculated. The plasmid copy number was calculated using the following formula: Plasmid copy number (copies/μL) = [Plasmid concentration (g/μL) × 6.02×10²³] / [Plasmid length (bp) × 660 g/mol] Plasmid pMD19-mgc2 was subjected to ten-fold dilutions at a gradient range from 10⁷ to 10° copies/μL and stored at −20°C. Sensitivity tests of RAA-LFD, PCR, and qPCR Serial dilutions of the plasmid pMD19-mgc2 (concentration range: 1.8 × 10⁷ to 1.8 × 10⁰ copies/μL) were used as templates to determine the sensitivity of three methods: RAA-LFD, PCR, and qPCR. RAA-LFD detection was performed under the aforementioned optimal conditions. The primers used for PCR detection were consistent with those for RAA-LFD detection, with an annealing temperature of 71°C; the remaining reaction system and operating steps were the same as those employed in the construction of the standard plasmid. For qPCR detection, the TB Green Real-Time PCR Kit (Takara Biotech Co., Ltd., Beijing, China) was adopted, with the same primers as those used for PCR. The 25 μL qPCR reaction system was composed of 12.5 μL of qPCR Mix, 1 μL of forward primer (10 μM), 1 μL of reverse primer (10 μM), 1 μL of template, and 9.5 μL of sterile water. The reaction program was set as follows: the reaction mixture was first pre-denatured at 95°C for 30 s; subsequently, 40 cycles were performed, each consisting of denaturation at 95°C for 15 s and annealing at 58°C for 5 s. Repeatability test Using the MG nucleic acid detection method established in this study, three intra-assay and inter-assay repeatability tests were performed with recombinant plasmids at three concentrations (1.8 × 10⁴ copies/μL, 1.8 × 10³ copies/μL, and 1.8 × 10² copies/μL) as templates, and the amplification results were analyzed. Detection of clinical samples A total of 100 laryngeal swab samples were collected from chickens with suspected MG infection across 2 broiler farms in Shihezi city, Xinjiang Province, China. These chickens exhibited clinical signs including joint enlargement, movement disorder, difficulty breathing, stunted growth, decreased egg production, sinusitis or conjunctivitis. None of the chickens had been vaccinated against MG or MS. All samples were tested using the RAA assay, PCR, and qPCR. Results Screening of primers and probes In this study, four pairs of primers were designed targeting the mgc2 and pvpA genes of MG strains for RAA amplification analysis. After purification, the amplified products were detected by 2% agarose gel electrophoresis. Results showed that all designed primer pairs could generate specific bands of the expected size; among them, the MG F1/MG R1 primer pair produced the brightest and clearest bands with the fewest non-specific bands (Fig. 2A). Thus, the MG F1/MG R1 primer pair was selected as the optimal combination for subsequent experiments. To avoid potential false-positive signals in LFD detection, two sets of probes were designed, and RAA-LFD detection was performed using MG F1/MG R1b. Results indicated that both primer-probe combinations exhibited positive reaction bands on the dipstick; however, in the no-template negative control, a false-positive band appeared at the test line position for MG F1/MS R1b/Probe 1, while no bands were observed for MG F1/MG R1b/Probe 2 (Fig. 2B). Finally, MG F1/MG R1b/Probe 2 was chosen as the primer-probe combination for subsequent experiments. Screening of primers and probe for MG detection. (A) The agarose gel electrophoresis results of the RAA products amplified with different primers are displayed as grayscale images under the gel imaging system. M: DNA marker DL3000. 1, 2,3, 4: Positive reactions using primer pairs No.1-No.4, respectively; N: Blank Control. The primer pair of No.1 (MG F1/MG R1) was selected for subsequent experiments. (B) The optimal primer pair MG F1/MG R1b was used for RAA-LFD probe screening. 1: MG F1/MG R1b/Probe 1 primer set tested positive; 2: MG F1/MG R1b/Probe 1 no-template control tested positive; 3: MG F1/MG R1b/Probe 2 primer set tested positive; 4: MG F1/MG R1b/Probe 2 no-template control tested negative. Probe 2 was ultimately selected as the optimal probe for RAA-LFD detection. Abbreviations: MG: Mycoplasma gallisepticum; RAA: Recombinase-aided amplification; RAA-LFD: Recombinase-aided amplification combined with lateral flow dipstick. Optimization of RAA reaction primer concentration, probe concentration, temperature and time With other conditions kept unchanged, a primer concentration gradient was set up. As shown in Fig. 3A, clear test bands could be observed within the primer concentration range of 0.5 μM to 4 μM, and the bands were brighter at 1.5 μM to 4 μM. After comprehensive consideration, a final primer concentration of 1.5 μM was selected, with 2 μL of each forward and reverse primer added. Next, screening of the RAA-LFD probe concentration was performed. As shown in Fig. 3B, clear test bands could be observed within the probe concentration range of 0.5 μM to 4 μM, and the bands were brighter at 1.5 μM to 4 μM. Thus, a lower probe concentration (1.5 μM) within this range was chosen for subsequent RAA assays, with 0.6 μL of the probe added. The optimal reaction temperature for the RAA-LFD assay was determined. As shown in Fig. 3C, bands could be detected within the temperature range of 30°C to 39°C, among which the band intensity was the highest at 39°C. Therefore, 39°C was selected as the reaction temperature for subsequent RAA-LFD assays. Subsequently, the optimal reaction time for the RAA-LFD assay was further determined (Fig. 3D). Results showed that clear and distinguishable target bands could be observed within the range of 10 to 30 minutes, and the band intensity was optimal at 20 to 30 minutes. Consequently, a shorter time period (20 minutes) within this range was chosen for subsequent experiments. Optimization of reaction conditions for MG detection by RAA-LFD. (A) RAA-LFD results under different primer concentrations. Of the range of primer concentrations, 1.5 μM was selected as the optimal reaction primer concentration. (B) RAA-LFD results under different probe concentrations. Of the range of probe concentrations, 1.5 μM was selected as the optimal reaction primer concentration. (C) RAA-LFD results under different temperatures. Of the range of tested temperatures, 39°C was selected as the optimal reaction temperature. (D) RAA-LFD results under different reaction time. Of the range of tested time, 20 min was selected as the optimal reaction time. Specificity test The nucleic acids of MG and ten other chicken pathogens were used as templates to evaluate the specificity of the RAA-LFD detection method. The results showed that all MG strains produced target bands after agarose gel electrophoresis, while the DNA of other bacteria yielded negative results (Fig. 4A). This indicates that the RAA-LFD method for MG detection has excellent specificity and shows no cross-reactivity with other common chicken pathogens. Performance evaluation of MG RAA-LFD. (A) Specificity test of RAA-LFD for MG detection. 1-4: RAA-LFD detection results of MG strains SHZ-1, SHZ-2, SHZ-3, and SHZ-4, respectively; 5-14: Results of RAA-LFD detection for Mycoplasma synoviae, Mycoplasma bovis, Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis, respectively; 15: Negative control. (B) Sensitivity test of RAA-LFD. 1-8: RAA-LFD detection results with MG DNA template of 1.8 × 107−1.8 × 10° copies/μL, respectively; 9: Negative control. The lowest detection limit of RAA-LFD was 1.8 × 101 copies/μL. (C) Sensitivity test of PCR. 1-8: PCR detection results with MG DNA template of 1.8 × 107−1.8 × 10° copies/μL, respectively; 9: Negative control. The lowest detection limit of PCR was 1.8 × 103 copies/μL. (D) Sensitivity test of qPCR. 1-8: qPCR detection results with MG DNA template of 1.8 × 107−1.8 × 10° copies/μL, respectively; 9: Negative control. The lowest detection limit of qPCR was 1.8 copies/μL. (E) MG RAA-LFD Inter-group Repeatability Test. 1: 1.8 × 10⁴ copies/μL; 2: 1.8 × 10³ copies/μL; 3: 1.8 × 102 copies/μL. (F) MG RAA Intra-group Repeatability Test. 1-3: 1.8 × 10⁴ copies/μL; 4-6: 1.8 × 10³ copies/μL; 7-9: 1.8 × 102 copies/μL. Comparison of the sensitivity of RAA, PCR and qPCR The sensitivity of RAA-LFD, PCR, and qPCR was tested and compared. The results showed that the detection limits of these three methods were 1.8 × 10¹ copies/μL, 1.8 × 10³ copies/μL, and 1.8 copies/μL, respectively (Fig. 4B-D), indicating that the sensitivity of RAA-LFD detection is 100 times higher than that of PCR but lower than that of qPCR. Repeatability test The established RAA-LFD method underwent intra-assay and inter-assay repeatability tests. The results of the inter-assay repeatability test are shown in Fig. 4E. For MG, recombinant plasmids at three different concentrations (1.8 × 10⁴ copies/μL, 1.8 × 10³ copies/μL, and 1.8 × 10² copies/μL) were grouped and tested in three repeated experiments. Clear test bands appeared at all three concentrations, and the band intensity remained largely consistent across the three repeated trials. The results of the intra-assay repeatability test are shown in Fig. 4F. For MG, clear test bands were observed at all three concentrations (1.8 × 10⁴ copies/μL, 1.8 × 10³ copies/μL, and 1.8 × 10² copies/μL), with highly consistent band intensity across each concentration. This demonstrates that the MG RAA-LFD method established in this study exhibits excellent repeatability and reproducibility. Detection of clinical samples Three methods (RAA-LFD, PCR, and qPCR) were used for simultaneous detection of 100 clinical samples suspected of MG infection. Results showed that the positive rate of RAA-LFD was 58% (58/100), while those of PCR and qPCR were 54% (54/100) and 60% (60/100), respectively. The concordance rate between RAA-LFD and PCR was 96%, and that between RAA-LFD and qPCR was 98% (Table 2). It is noteworthy that all 54 PCR-positive samples were positive in RAA-LFD detection, with a sensitivity (positive agreement rate) of 100%. Among the 46 PCR-negative samples, 42 were also negative in RAA-LFD detection, resulting in a specificity (negative agreement rate) of 91.3%. Compared with the PCR method, the RAA-LFD assay established in this study had a Kappa value of 0.9 (Table 3). These results indicated that the RAA-LFD assay developed in this study can be used for the detection of MG in clinical samples. Table 2Detection of Mycoplasma gallisepticum in 100 clinical laryngeal swab samples from chickens using the RAA-LFD assay compared with PCR and RFQ-PCR.Table 2 dummy alt textMethodsPositive casesNegative casesPositive rate (%)Coincidence rate (%)RAA584258-PCR54465496RFQ-PCR60406098RAA: recombinase-aided amplification; RFQ-PCR: real-time fluorescence quantitative PCR. Detection of Mycoplasma gallisepticum in 100 clinical laryngeal swab samples from chickens using the RAA-LFD assay compared with PCR and RFQ-PCR. RAA: recombinase-aided amplification; RFQ-PCR: real-time fluorescence quantitative PCR. Table 3Diagnostic performance of the RAA-LFD assay using PCR and qPCR as the reference method for the detection of Mycoplasma gallisepticum in 100 clinical laryngeal swab samples from chickens.Table 3 dummy alt textPCRPerformance characteristicsPositiveNegativeSensitivity (%)Specitivity (%)PPV (%)NPV (%)KappaRAAPositive54410091.393.11000.923Negative046RAA: recombinase-aided amplification; PPV: positive predictive value; NPV: negative predictive value. Diagnostic performance of the RAA-LFD assay using PCR and qPCR as the reference method for the detection of Mycoplasma gallisepticum in 100 clinical laryngeal swab samples from chickens. RAA: recombinase-aided amplification; PPV: positive predictive value; NPV: negative predictive value. Discussion Mycoplasma gallisepticum is the most pathogenic among the 26 known avian mycoplasma species (Klostermann and Lierz, 2023). It can be transmitted both vertically and horizontally, and is widely distributed in all poultry-raising countries around the world (Kursa et al., 2024). Moreover, it is often secondary to or concurrent with infectious diseases such as Newcastle Disease, Infectious Bronchitis, Haemophilus paragallinarum disease, and Escherichia coli infection, causing substantial economic losses to the poultry industry (Liu et al., 2025a). A rapid, accurate, and convenient detection method is crucial for the early clinical diagnosis and prevention of MG infection. Isothermal nucleic acid amplification technology has developed rapidly due to its advantages of visualization, simple operation, high efficiency, and low cost, particularly RAA and RPA (Bi et al., 2025; Zhang et al., 2026). RAA is an optimized version of RPA technology, offering greater potential for promotion and application. The recombinase used in RAA is derived from bacteria or fungi, which gives it a broader source and lower cost compared to the recombinase used in RPA (Bi et al., 2025). Currently, RAA technology has been successfully applied to the detection of various animal pathogens, such as Brucella (Liu et al., 2025b), novel duck orthoreovirus (Jiang et al., 2025), and Streptococcus equi (Zu et al., 2025). This study presents an RAA-LFD method for diagnosing MG by targeting the mgc2 gene of MG. Primers and probes are critical components of RAA-LFD detection. To achieve optimal amplification specificity and efficiency, the recommended primer length for RAA detection is 30–35 bp, and the probe length is 46–52 bp (Zhao et al., 2021). However, longer primers and probes may form secondary structures, and the chemical modifications on both the reverse primer and the probe can easily generate false-positive signals in LFD detection (Li et al., 2023; Yin et al., 2025). Therefore, screening of primers and probes is necessary for RAA detection. In this experiment, the optimal primer combination MG F1/MG R1/Probe 2 was selected for MG detection. Using this combination (primer concentration 1.5 μM, probe concentration 1.5 μM), the RAA reaction was completed within 20 minutes at 39°C, and the amplification products could be detected via LFD within 5 minutes without generating false-positive signals. Currently, PCR and qPCR are the primary techniques for molecular detection of MG in most laboratories (Galluzzo et al., 2022; Kang et al., 2023). To evaluate the performance of the RAA detection method for MG, we compared it with laboratory-developed PCR and qPCR methods. The limits of detection for MG by PCR and qPCR were 1.8 × 10³ copies/μL and 1.8 copies/μL, respectively, consistent with data from relevant literature (Wang et al., 2024), confirming the reliability of our two methods as controls for RAA. This study demonstrated that the RAA-LFD detection method achieves a sensitivity of 10¹ copies/μL. While PCR and qPCR require expensive thermal cyclers and experienced technicians, the RAA-LFD method developed in this study can be easily performed in a water bath, with results visually interpreted by observing bands on the lateral flow dipstick. The diagnostic system developed in this study is also suitable for non-specialists. Users only need to mix the required reagents with the nucleic acid sample to be tested. The reaction then proceeds in a water bath, and detection is carried out using a lateral flow dipstick. Pipettes and a water bath are the main instruments required for the assay, highlighting its potential for on-site deployment of MG identification. Recent studies have shown that researchers have combined RPA with an Argonaute protein from Pyrococcus furiosus to detect MG. This method allows visual observation under blue light or ultraviolet light (Zhao et al., 2025). However, it requires additional equipment such as blue light for visual inspection or an imaging system equipped with a UV transilluminator to capture images of the reaction tubes, with clear images obtained through connected computer software. Therefore, the RAA-LFD detection method is more suitable for MG infection diagnosis by grassroots breeding personnel. Conclusion In this study, an mgc2-based RAA-LFD detection method was established. Designed targeting the most conserved region of the MG genome in chickens, this method was validated for its effectiveness in the rapid and intuitive detection of MG-specific nucleic acids. The products amplified by RAA were detected via LFD visualization. This detection method exhibits excellent analytical sensitivity and specificity, as well as outstanding repeatability and reproducibility in MG detection. It is rapid and convenient, requiring no specialized equipment or highly skilled personnel, thus making it highly suitable for on-site diagnosis of MG and molecular epidemiological surveys in resource-limited settings or on-site environments. CRediT authorship contribution statement Huiyong Xuan: Writing – original draft, Investigation. Shu Wang: Methodology, Investigation, Formal analysis. XinYi Ren: Software, Formal analysis, Data curation. Fang Wang: Software, Formal analysis. Gang Lu: Supervision, Methodology. Hongwei Gao: Methodology, Formal analysis. Yaocheng Cui: Writing – review & editing, Funding acquisition. Disclosures The authors declare no conflicts of interest. Acknowledgments This work was supported by Corps Finance and Administration [2024] No.97-2024 Talent Development Fund-Tianchi Talents (the Second Batch) for Young Doctors (CZ004312); Corps Finance and Administration [2024] No.97-2024 Talent Development Fund-Tianchi Talents (the Second Batch) for Young Doctors (CZ004309); the University-level High-Level Talent Project of Shihezi University in Xinjiang Province, China (RCZK202454); University-level High-Level Talent Project of Shihezi University in Xinjiang Province, China (RCZK202455). Footnotes The appropriate scientific section: Immunology, Health and Disease Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.psj.2026.107035. Supplementary materials References Associated Data Supplementary Materials